Cargando…
Comorbidities for fatal outcome among the COVID-19 patients: A hospital-based case-control study
Autores principales: | Lu, Qing-Bin, Jiang, Wan-Li, Zhang, Xin, Li, Hui-Jun, Zhang, Xiao-Ai, Zeng, Hao-Long, Du, Juan, Yang, Guo-Liang, Zhang, Lei-Ke, Li, Rui, Fang, Li-Qun, Li, Hao, Liu, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Ltd on behalf of The British Infection Association.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7384426/ https://www.ncbi.nlm.nih.gov/pubmed/32731000 http://dx.doi.org/10.1016/j.jinf.2020.07.026 |
Ejemplares similares
-
The differential demographic pattern of coronavirus disease 2019 fatality outside Hubei and from six hospitals in Hubei, China: a descriptive analysis
por: Lu, Qing-Bin, et al.
Publicado: (2021) -
Neurological manifestations in COVID-19 patients and their application in predicting fatal disease: A retrospective cohort study
por: Zhao, Tian-Shuo, et al.
Publicado: (2022) -
Important factors affecting COVID-19 transmission and fatality in metropolises
por: Cao, W., et al.
Publicado: (2021) -
Circulating cell-free BRAF V600E during chemotherapy is associated with prognosis of children with Langerhans cell histiocytosis
por: Cui, Lei, et al.
Publicado: (2020) -
Comment on “Hyperglycemia in pregnancy: sleep alterations, comorbidities and pharmacotherapy”
por: Guo, Rui, et al.
Publicado: (2022)